Switzerland-based Type 2 diabetes treatment provider Oviva announced it has raised $21 million (€18.8 million) in Series B funding.
The round was led by Swiss healthtech investor MTIP, joined by Earlybird as new investors. Existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech all participated.
It brings the total amount raised by Oviva to date to $34 million (€30.5...
